disopyramide has been researched along with Diabetes Mellitus, Type 2 in 4 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Disopyramide (Norpace) is a widely used, generally well tolerated antiarrhythmic agent." | 5.27 | Hypoglycemic coma due to disopyramide toxicity. ( Gillman, MW; Stapleton, JT, 1983) |
| "Disopyramide, an antiarrhythmia drug, has been reported to cause hypoglycaemia." | 3.75 | Mechanism of disopyramide-induced hypoglycaemia in a patient with Type 2 diabetes. ( Mori, M; Negishi, M; Proks, P; Shimomura, K; Shimomura, Y, 2009) |
| "Disopyramide (Norpace) is a widely used, generally well tolerated antiarrhythmic agent." | 1.27 | Hypoglycemic coma due to disopyramide toxicity. ( Gillman, MW; Stapleton, JT, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Negishi, M | 1 |
| Shimomura, K | 1 |
| Proks, P | 1 |
| Mori, M | 1 |
| Shimomura, Y | 1 |
| Stapleton, JT | 1 |
| Gillman, MW | 1 |
| Reynolds, RM | 1 |
| Walker, JD | 1 |
| Onoda, N | 1 |
| Kawagoe, M | 1 |
| Shimizu, M | 1 |
| Komori, T | 1 |
| Takahashi, C | 1 |
| Oomori, Y | 1 |
| Hirata, Y | 1 |
4 other studies available for disopyramide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Mechanism of disopyramide-induced hypoglycaemia in a patient with Type 2 diabetes.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Ang | 2009 |
Hypoglycemic coma due to disopyramide toxicity.
Topics: Aged; Coma; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disopyramide; Humans; Hypoglycemia; M | 1983 |
Hypoglycaemia induced by disopyramide in a patient with Type 2 diabetes mellitus.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diabetes Mellitus, Type 2; Disopyramide; Drug The | 2001 |
[A case of non-insulin dependent diabetes mellitus whose insulin requirement was markedly reduced after disopyramide treatment in arrhythmia].
Topics: Aged; Arrhythmias, Cardiac; Blood Glucose; Diabetes Mellitus, Type 2; Disopyramide; Female; Humans; | 1989 |